Jaguar Health, Inc. (NASDAQ:JAGX)

PRESS RELEASE

published on 12/17/2024 at 14:30, 1 year 1 month ago

FDA Approves Orphan-Drug Designation for Jaguar Health’s Crofelemer for Treatment of Diarrhea in Cholera
World Health Organization (WHO) elevates cholera to highest emergency level due to global resurgence. Crofelemer granted orphan-drug designation by FDA and EMA for cholera treatment

FDA Crofelemer Cholera Orphan-Drug Designation World Health Organization
BRIEF

published on 12/13/2024 at 16:05, 1 year 1 month ago

Ladenburg Thalmann to Host Scientific Showcase on Jaguar Health's Crofelemer

Crofelemer Jaguar Health Rare Diseases Napo Therapeutics Scientific Showcase
BRIEF

published on 12/13/2024 at 16:05, 1 year 1 month ago

Ladenburg Thalmann organise une exposition scientifique sur le Crofelemer de Jaguar Health

Crofelemer Maladies Rares Santé Jaguar Napo Thérapeutique Vitrine Scientifique
PRESS RELEASE

published on 12/13/2024 at 16:00, 1 year 1 month ago

Ladenburg Thalmann to Host Scientific Showcase December 18, 2024 About Rare Disease Clinical Development Efforts for Jaguar Health's Crofelemer
Jaguar Health, Inc. announces virtual event on crofelemer clinical development efforts for rare diseases MVID and SBS-IF. CEO awarded 'Best CEO BioPharmaceuticals of the Year'

Crofelemer Clinical Development Jaguar Health Rare Diseases MVID
BRIEF

published on 12/12/2024 at 15:05, 1 year 1 month ago

Le Crofelemer de Jaguar Health s'avère prometteur dans le traitement de la diarrhée liée à la thérapie contre le cancer

Crofelemer Essai Clinique Cancer Du Sein Diarrhée Liée Au Traitement Du Cancer SABCS
BRIEF

published on 12/12/2024 at 15:05, 1 year 1 month ago

Jaguar Health's Crofelemer Shows Promise in Treating Cancer Therapy-Related Diarrhea

Crofelemer Cancer Therapy-related Diarrhea Clinical Trial Breast Cancer SABCS
PRESS RELEASE

published on 12/12/2024 at 15:00, 1 year 1 month ago

Significant Positive Results with Jaguar Health's Crofelemer for Cancer Therapy-Related Diarrhea (CTD) in Breast Cancer Patients Presented at San Antonio Breast Cancer Symposium (SABCS)
Napo Pharmaceuticals presents statistically significant results of crofelemer in breast cancer patients for prophylaxis of CTD at SABCS. Study highlights impact of diarrhea in cancer treatment

Napo Pharmaceuticals Crofelemer Breast Cancer CTD SABCS
BRIEF

published on 12/09/2024 at 16:05, 1 year 1 month ago

Jaguar Health to Present Crofelemer Results at SABCS 2024

Crofelemer OnTarget Trial Breast Cancer CTD Prophylaxis SABCS 2024
BRIEF

published on 12/09/2024 at 16:05, 1 year 1 month ago

Jaguar Health présentera les résultats de Crofelemer au SABCS 2024

Crofelemer Essai OnTarget Cancer Du Sein SABCS 2024 Prophylaxie De La Maladie Du Tissu Conjonctif
PRESS RELEASE

published on 12/09/2024 at 16:00, 1 year 1 month ago

Poster Presentation Describing the Significant Results of Crofelemer for Cancer Therapy-Related Diarrhea (CTD) in Breast Cancer Patients to Take Place December 11, 2024 at San Antonio Breast Cancer Symposium (SABCS)
Jaguar Health's Napo Pharmaceuticals to present data on crofelemer in breast cancer patients at SABCS 2024. Additional analyses ongoing. Patient advocacy program also announced

Napo Pharmaceuticals Crofelemer Jaguar Health Breast Cancer SABCS 2024

Published on 01/31/2026 at 03:15, 1 day 5 hours ago

Empress Royalty Announces Grant Of Restricted Share Units
Published on 01/31/2026 at 02:20, 1 day 6 hours ago

Boron One Announces First Closing of Financing
Published on 01/31/2026 at 01:40, 1 day 6 hours ago

Star Copper Announces Grant of RSUs, Stock Options and PSUs
Published on 01/31/2026 at 00:00, 1 day 8 hours ago

BE Resources Announces Private Placement
Published on 01/30/2026 at 23:00, 1 day 9 hours ago

Avidian Gold Corp. Announces Director Resignation

View all ACCESSWIRE

Published on 01/31/2026 at 15:54, 16 hours 30 minutes ago

EQS-Adhoc: Wolford AG: Capital increase will not be implemented
Published on 01/31/2026 at 12:25, 19 hours 59 minutes ago

JOHNNIE WALKER TOASTS MUSIC'S BIGGEST WEEKEND WITH THE GO GO HIGHBALL
Published on 01/31/2026 at 02:45, 1 day 5 hours ago

CANADA BACKS NEW DEFENCE, SECURITY AND RESILIENCE BANK
Published on 01/30/2026 at 22:00, 1 day 10 hours ago

Nebius Group N.V. announces date of fourth quarter and full year 2025 results and conference call
Published on 01/30/2026 at 20:10, 1 day 12 hours ago

Cynosure Lutronic Announces Completion of EU MDR Approval and Global Momentum for Mosaic 3D™ Ahead of IMCAS 2026

View all EQS

Published on 01/30/2026 at 18:40, 1 day 13 hours ago

ICADE - Bilan semestriel du contrat de liquidite
Published on 01/30/2026 at 18:01, 1 day 14 hours ago

Emova Group - Résultats annuels 2024/25
Published on 01/30/2026 at 17:45, 1 day 14 hours ago

Schneider Electric launches a capital increase reserved for employees
Published on 01/30/2026 at 17:45, 1 day 14 hours ago

Schneider Electric lance une augmentation de capital réservée aux salariés
Published on 01/30/2026 at 08:30, 1 day 23 hours ago

Claude Bernard lance Senior+, un assistant IA conçu pour améliorer la prise en charge des patients les plus âgés

View all LES ECHOS COMFI WIRE

News